When to Start Insulin Therapy in Diabetes
Insulin therapy should be initiated immediately in patients with type 2 diabetes who have HbA1c ≥9%, blood glucose ≥300 mg/dL, or present with symptomatic hyperglycemia, ketosis, or unintentional weight loss. 1, 2
Indications for Insulin Therapy
Immediate Initiation (Start Now)
- Newly diagnosed T2DM with:
Delayed Initiation (After Oral Therapy Trial)
- Failure to achieve glycemic targets after 3-6 months of:
- Contraindications to oral antidiabetic medications 3
- Acute illness, surgery, or pregnancy 3
Starting Insulin Regimens
For Immediate Initiation
- Basal insulin plus mealtime insulin is the preferred initial regimen for severely symptomatic patients 1
For Delayed Initiation
Basal insulin only:
Premixed insulin:
Insulin Titration Algorithm
For Basal Insulin
- Increase by 2 units if fasting glucose remains above target for 3 consecutive days 2
- Decrease by 10-20% if hypoglycemia occurs 2
For Prandial Insulin
- Correction doses for blood glucose >180 mg/dL:
- 150-200 mg/dL: Add 2 units
- 201-250 mg/dL: Add 4 units
- 251-300 mg/dL: Add 6 units
300 mg/dL: Add 8 units and notify provider 2
When to Intensify Insulin Therapy
If HbA1c remains above target after optimizing basal insulin:
- Add GLP-1 receptor agonist (preferred option) 2
- Add prandial insulin before largest meal 1, 2
- Progress to basal-bolus regimen (multiple daily injections) 1
Common Pitfalls and How to Avoid Them
Therapeutic Inertia
- Pitfall: Delaying insulin initiation despite persistent hyperglycemia
- Solution: Do not delay insulin therapy in patients not achieving glycemic goals (HbA1c target) after 3 months of oral therapy 1
Hypoglycemia Risk
- Pitfall: Aggressive insulin titration leading to hypoglycemia
- Solution: Start with lower doses (0.1 units/kg) in elderly patients and titrate more cautiously 2
- Solution: Use long-acting insulin analogs which have less overnight hypoglycemia than NPH insulin 2
Weight Gain
- Pitfall: Insulin-associated weight gain
- Solution: Maintain metformin when starting insulin to minimize weight gain 2
- Solution: Consider adding SGLT2 inhibitors which can reduce total daily insulin dose and promote weight loss 1
Special Considerations
Renal Impairment
- Patients with stage 3 renal failure have increased hypoglycemia risk due to decreased insulin clearance 2
- Lower starting doses and more cautious titration are recommended
Elderly Patients
- Start at lower end of dosing range (0.1 units/kg) 2
- Consider less stringent HbA1c goals (such as <8%) for patients with limited life expectancy or extensive comorbidities 1
By following these guidelines, insulin therapy can be initiated at the appropriate time to improve glycemic control and reduce the risk of diabetes-related complications.